Zimbabwe has declined a significant American healthcare agreement valued at $367m (£272m) spanning five years over Washington's demand for confidential biological samples.
This rejection came to light following a official document from December was leaked, revealing that President Emmerson Mnangagwa believed the deal was "skewed".
A government spokesman has since explained that the United States was seeking genetic material for research and commercial purposes while refused to guarantee the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for further negotiations to find a agreement acceptable to both sides so the country's critical HIV programme can continue.
Wider Implications
This rejection comes after a similar situation in neighbouring Kenya, where a high court suspended a similar deal with the US following legal challenges were raised about the safety of citizens' health data.
After resuming the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral deals to boost openness and responsibility.
As per statements, Sixteen nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn in new funding.
Details of the Declined Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to share its genetic material and health information for a long time, without any corresponding assurance of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," Mangwana explained.
"In essence, our nation would supply the raw materials for medical research with no certainty that the final treatments would be accessible to our citizens if a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining frameworks previously set up through the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing system designed to manage potential global health emergencies.
"This system is intended to guarantee that when a nation contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to further discussions with our US partners on how future co-operation could be designed in a way that respects the independence and dignity of each country."
Medical Community Response
A leading public health body expressed it understood the official position, but recommended that talks should continue given that a large portion of the nation's HIV programmes were funded by foreign aid.
"In cases where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group said.
This impasse highlights the continuing challenges between receiving much-needed foreign assistance and protecting national sovereignty in an ever more interconnected world.